Palisade Bio (PALI) FCF Margin (2011 - 2023)

Palisade Bio (PALI) has 11 years of FCF Margin data on file, last reported at 1410.4% in Q1 2023.

• FCF Margin for Q1 2023 came in at 1410.4%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was 4453.2% (changed N/A YoY), and the FY2023 annual result was 4454.8%, changed N/A from the prior year.
• FCF Margin rose to 1410.4% in Q1 2023 per PALI's latest filing, from 61960.0% in the prior quarter.
• Over five years, FCF Margin peaked at 1410.4% in Q1 2023 and troughed at 81957.28% in Q4 2019.
• A 3-year average of 44244.09% and a median of 34720.0% in 2020 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2019 and 2020: FCF Margin slumped 1982152 bps in 2019, then surged 4116960 bps in 2020.
• A 3-year view of FCF Margin shows it stood at 81957.28% in 2019, then increased by 24 bps to 61960.0% in 2020, then jumped by 98 bps to 1410.4% in 2023.
• Business Quant data shows PALI's FCF Margin at 1410.4% in Q1 2023, 61960.0% in Q4 2020, and 34720.0% in Q3 2020.